Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

NIH to evaluate Isotechnika Pharma portfolio

April 12, 2012

SkyePharma signs second development contract with RespiVert

April 12, 2012

Nuron Biotech obtains worldwide license for candidate AD vaccine

April 12, 2012

AnaptysBio enters strategic antibody discovery partnership

April 11, 2012

Sanofi and Alfresa Pharma launch vigabatrin collaboration

April 10, 2012

Newron and Zambon provide update on safinamide

April 5, 2012

Xencor receives milestone payment from Boehringer Ingelheim

April 5, 2012

Fresenius Medical Care gains marketing rights to TRK-820

April 5, 2012

LabCorp licenses diagnostic technology for Alzheimer's disease

April 5, 2012

Ajinomoto in-licenses IBAT inhibitor

April 4, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...